Cytogenetic tests
Jump to navigation
Jump to search
Thsi article is a list of common cytogenetic tests. An introduction to cytogenetics is in the cytogenetics article.
Karyotyping
Findings:
ISH
Cytogenetic tests at one hospital:[3]
Test | Parameters | Notes |
---|---|---|
BCR/ABL1 | CML or ALL | Tx (imatinib) |
MLL | ALL or AML | rearrangment --> marker of poor prognosis[4] |
MYC | Burkitt's lymphoma + others | prognostic |
ALK | DLBCL - BCL6, BCL2 or MYC | ? |
MALT1 | MALT lymphoma | trisomy 3, trisomy 18 |
CCND1 | mantle cell lymphoma | ? |
BCL2 | follicular lymphoma | |
ERBB2 (HER2) | breast cancer | prognostic, Tx (trastuzumab) |
EWSR1 | small round blue cell tumour (suspected Ewing sarcoma) |
See also
References
- ↑ Nimer, SD. (Jun 2006). "Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.". J Clin Oncol 24 (16): 2576-82. doi:10.1200/JCO.2005.03.6715. PMID 16735711.
- ↑ Mallo, M.; Luño, E.; Sanzo, C.; Cervera, J.; Haase, D.; Schanz, J.; García-Manero, G.; Del Cañizo, C. et al. (Jan 2011). "Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.". Leuk Res. doi:10.1016/j.leukres.2011.01.003. PMID 21269692.
- ↑ Kamel-Reid, Suzanne. University Health Network / Department of Pathology. Cancer Cytogenetics & Molecular Diagnostics Laboratories. Test Requisition. August 2010.
- ↑ Liedtke, M.; Cleary, ML. (Jun 2009). "Therapeutic targeting of MLL.". Blood 113 (24): 6061-8. doi:10.1182/blood-2008-12-197061. PMID 19289854.